Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats

Journal of Lipid Research

Volumn 46, Issue 9, 2005, Pages 1823-1832

  Tovar, Armando R ^a   Torre Villalvazo, Ivan ^a   Ochoa, Melissa ^a   Elías, Ana L ^a   Ortíz, Victor ^a   Aguilar Salinas, Carlos A ^a   Torres, Nimbe ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Liver; Liver X receptor ; Steatosis; Sterol regulatory element binding protein 1

Indexed keywords

ABC TRANSPORTER A1; ACYL COENZYME A DESATURASE; CASEIN; CHOLESTEROL; DELTA5 DESATURASE; GENE PRODUCT; INSULIN; LINOLEOYL COENZYME A DESATURASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; STEROID 7ALPHA HYDROXYLASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; FATTY LIVER; GENE OVEREXPRESSION; HYPERINSULINEMIA; HYPERLEPTINEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER LIPOTOXICITY; LIVER TOXICITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN INTAKE; RAT; RAT STRAIN;

ADIPOSE TISSUE; ANIMALS; CASEINS; CCAAT-ENHANCER-BINDING PROTEINS; CHOLESTEROL; CHOLESTEROL, LDL; DIET; DNA-BINDING PROTEINS; FATTY LIVER; GENE EXPRESSION; HYPERINSULINISM; LIPID METABOLISM; LIPOPROTEINS, VLDL; LIVER; MALE; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SOYBEAN PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 24344472642     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500067-JLR200     Document Type: Article

References (44)

1. Browning, J. D., L. S. Szczepaniak, R. Dobbins, P. Nuremberg, J. D. Horton, J. Cohen, S. M. Grundy, and H. Hobbs. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40: 1387-1395.
2. Marchesini, G., M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A. J. McCullough, S. Natale, G. Forlani, and N. Melchionda. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50: 1844-1850.
3. Browning, J. D., and J. D. Horton. 2004. Molecular mediators of hepatic steatosis. J. Clin. Invest. 114:147-152.
4. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
5. Shimano, H., J. D. Horton, R. E. Hammer, I. Shimomura, M. S. Brown, and J. L. Goldstein. 1996. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98: 1575-1584.
6. Chen, G., G. Liang, J. Ofu, J. L. Goldstein, and M. S. Brown. 2004. Central role for liver X receptor in insulin-mediated activation of SREBP-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. USA. 101: 11245-11250.
7. Repa, J. J., G. Liang, J. Ou, Y. Bashmakov, J. A. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, and D. J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-lc gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14: 2819-2830.
8. Zhang, Y., and D. J. Mangelsdorf. 2002. LuXuRies of lipid homeostasis. Mol. Intent. 2: 78-87.
9. Russell, A. D., J. Ou, J. L. Goldstein, and M. S. Brown. 2001. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc. Natl. Acad. Sci. USA. 98: 1477-1482.
10. Anderson, J. W., B. M. Johnstone, and M. E. Cook-Newell. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333: 276-282.
11. Tovar, A. R., F. Murguia, C. Cruz, R. Hernandez-Pando, C. A. Aguilar-Salinas, J. Pedraza-Chaverri, R. Correa-Rotter, and N. Torres. 2002. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569.
12. Zhan, S., and S. C. Ho. 2005. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 81: 397-408.
13. Ascencio, C., N. Torres, F. Isoard-Acosta, F. J. Gómez- Pérez, R. Hernández-Pando, and A. R. Tovar. 2004. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J. Nutr. 134: 522-529.
14. Tovar, A. R., C. Ascencio, and N. Torres. 2002. Soy protein, casein, and zein regulate histidase gene expression by modulating serum glucagon. Am. J. Physiol. 283: E1016-E1022.
15. Peterson, R. G., W. N. Shaw, M. A. Neel, L. A. Little, and J. Eichberg. 1990. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. Ilar News. 32: 16-19.
16. Phillips, M. S., Q. Liu, H. A. Hammond, V. Dugan, P. J. Hey, C. J. Caskey, and J. F. Hess. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13: 18-19.
17. Folch, J., M. Lees, and G. H. Sloane-Stanley. 1957. Asimple method for the isolation and purification of total lipids from animal tissues. J. Eur. Chem. 226: 497-509.
18. Aguilar-Salinas, C. A., P. H. Barrett, J. Kelber, J. Delmez, and G. Schonfeld. 1995. Physiologic mechanisms of action of lovastatin in nephrotic syndrome. J. Lipid Res. 36: 188-199.
19. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
20. Berry, M. N., and D. S. Friend. 1969. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J. Cell Biol. 43: 506-520.
21. Unger, R. H., and L. Orci. 2001. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15: 312-321.
22. Cohen, P., and J. M. Friedman. 2004. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J. Nutr. 134 (Suppl.): 2455-2463.
23. Kim, J. B., P. Sarraf, M. Wright, K. M. Yao, E. Mueller, G. Solanes, B. B. Lowell, and B. M. Spiegelman. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 101: 1-9.
24. Matsuzaka, T., H. Shimano, N. Yahagi, M. Amemiya-Kudo, T. Yoshikawa, A. H. Hasty, Y. Tamura, J. Osuga, H. Okazaki, Y. Iizuka, et al. 2002. Dual regulation of mouse Delta5- and Delta6-desturase gene expression by SREBP-1 and PPARα. J. Lipid Res. 43: 107-114
25. Jump, D. B., and S. D. Clarke. 1999. Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 19: 63-90.
26. Banz, W. J., J. Davis, R. Peterson, and M. J. Iqbal. 2004. Gene expression and adipocity are modified by soy protein in male Zucker diabetic fatty rat. Obes. Res. 12: 1907-1913.
27. Hussain, M. M., J. Shi, and P. Dreizen. 2003. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J. Lipid Res. 44: 22-32.
28. Adiels, M., C. Packard, M. J. Caslake, P. Stewart, A. Soto, J. Westerbacka, B. Wennberg, S. Olofsson, M. Taskinen, and J. Borén. 2005. A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J. Lipid Res. 46: 58-67.
29. Chiang, J., Y. Kimmel, and G. Stroup. 2001. Regulation of cholesterol 7 alpha-hydroxylase gene (CYP 7 A1) transcription by the liver orphan receptor (LXRalpha). Gene. 262: 257-267.
30. Repa, J. J., S. D. Turley, J. A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, and D. J. Mangelsdorf. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 289: 1524-1529.
31. Takaishi, K., L. Duplomb, M. Wang, J. Li, and R. H. Unger. 2004. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc. Natl. Acad. Sci. USA. 101: 7106-7111.
32. Weigman, C. H., R. H. Bandsma, M. Omvens, F. van der Sluijs, R. Havinga, T. Boer, D. Reijngoud, J. A. Romijn, and F. Kuipers. 2003. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes. 52: 1081-1089.
33. Yahagi, N., H. Shimano, A. Hasty, T. Matzuzaka, T. Ide, T. Yoshikawa, M. Amerniya-Kudo, S. Tomita, H. Okasaki, Y. Tamura, et al. 2002. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice. J. Biol. Chem. 277: 19353-19357.
34. Shimano, H., J. D. Horton, I. Shimomura, R. E. Hammer, M. S. Brown, and J. L. Goldstein. 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice in cultured cells. J. Clin. Invest. 99: 846-854.
35. Shimomura, I., Y. Bashmakov, and J. D. Horton. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274: 30028-30032.
36. Potter, S. M., J. A. Baum, H. Teng, R. J. Stillman, N. F. Shay, and J. W. Erdman. 1998. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68 (Suppl.): 1375-1379.
37. Mullen, E., R. Brown, T. Osborne, and N. Shay. 2004. Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells. J. Nutr. 134: 2942-2947.
38. Weggemans, R. M., and E. A. Trautwein. 2003. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur. J. Clin. Nutr. 57: 40-46.
39. Pittas, A. G., N. A. Joseph, and A. S. Greenberg. 2004. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 89: 447-452.
40. Rangwala, S. M., and M. A. Lazar. 2004. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol. Sci. 25: 331-336.
41. Lu, T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, and D. J. Mangelsdorf. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell. 6: 507-515.
42. Horton, J. D., J. A. Cuthbert, and D. K. Spady. 1995. Regulation of hepatic 7 α-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J. Biol. Chem. 270: 5381-5387.
43. Repa, J. J., K. E. Berge, C. Pomajzl, J. A. Richardson, H. Hobbs, and D. J. Mangelsdorf. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the X receptors α and β. J. Biol. Chem. 277: 18793-18800.
44. Basso F., L. Freeman, C. L. Knapper, A. Remaley, J. Stonik, E. B. Neufeld, T. Tansey, M. J. Amar, J. Fruchart-Najib, N. Duverger, et al. 2003. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J. Lipid Res. 44: 296-302.